Evaluation of Exposure-Response Relationships Using Clinical Data: Basic Concepts and Applications-Reference-Cited by-同舟云学术

Evaluation of Exposure-Response Relationships Using Clinical Data: Basic Concepts and Applications

Published:2016 Issue: Volume: Page:127-157
ISSN:1557-2153
Container-title:Methods in Pharmacology and Toxicology
language:
Short-container-title:

Author:

Bhavnani Sujata M.,Rubino Christopher M.,Ambrose Paul G.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-3323-5_6

Reference65 articles.

1. Dubois A, Lavielle M, Gsteiger S, Pigeolet E, Mentré F (2011) Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximization algorithm. Stat Med 30:2582–2600

2. Food and Drug Administration, U.S. Department of Health and Human Services (1999) Guidance for industry: population pharmacokinetics (Clinical Pharmacology)

3. Steimer JL, Mallet A, Golmard JL, Boisvieux JF (1984) Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metab Rev 15:265–292

4. Ette EI, Williams PJ (2004) Populations pharmacokinetics I: background, concepts, and models. Ann Pharmacother 38:1702–1706

5. Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5:445–479

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients;Antimicrobial Agents and Chemotherapy;2021-08-17

2. Clinical pharmacokinetic–pharmacodynamic analyses: a critical element for developing antibacterial agents;Current Opinion in Pharmacology;2017-10